Characteristics of older adults who meet the annual prescription drug expenditure threshold for medicare medication therapy management programs

Journal of Managed Care Pharmacy

Volumn 13, Issue 2, 2007, Pages 142-154

  Daniel, Gregory W ^a   Malone, Daniel C ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Drug prescriptions; Insurance; Medicare Part D; Medication therapy management; Pharmaceutical services

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIANGINA PECTORIS AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIESTROGEN; ANTIHISTAMINIC AGENT; ANTITHYROID AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILE ACID SEQUESTRANT; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYPNOTIC AGENT; MISCELLANEOUS DRUGS AND AGENTS; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SALICYLIC ACID; SEDATIVE AGENT; TOPICAL AGENT;

AGED; ANALYTICAL ERROR; ARTICLE; BODY MASS; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEMOGRAPHY; DIABETES MELLITUS; DRUG COST; DYSLIPIDEMIA; FEMALE; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HEALTH STATUS; HEALTH SURVEY; HEART DISEASE; HUMAN; LIFESTYLE MODIFICATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PHARMACEUTICAL CARE; PRESCRIPTION; SOCIAL STATUS; ULCER;

EID: 33947623626     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2007.13.2.142     Document Type: Article

References (55)

1. Dept. of Health and Human Services, Centers for Medicare & Medicaid Services. Key milestones in CMS programs. October 7, 2004. Available at: http://www.cms.hhs.gov/History/Downloads/CMSProgramKeyMilestones.pdf. Accessed November 15, 2005.
2. American Society of Consultant Pharmacists. ASCP issue paper: medication therapy management services - status update, August 4, 2005. Available at: http://www.ascp.com/medicarerx/docs/MTMSUpdateIP.pdf. Accessed December 16, 2005. Available at: http://www.ascp.com/medicarerx/upload/ MTMSUpdateIP.pdf. Accessed December 16, 2006.
3. Summary of the executive sessions on medication therapy management programs, Bethesda, Maryland, June 14 and August 18, 2004. Am J Health Syst Pharm. 2005;62:585-92.
4. Dept. of Health and Human Services, Centers for Medicare & Medicaid Services Medicare program; Medicare prescription drug benefit; final rule. Federal Register 2005;70:4193-742.
5. Da Vanzo J, Dobson A, Koenig L, Book R. Medication therapy management services: a critical review: executive summary report. May 17, 2005. Available at: http://www.accp.com/position/mtms.pdf. Accessed December 16, 2005.
6. Agency for Healthcare Research and Quality. MEPS HC-036: 1996-2004 Pooled estimation fine; 2005. Available at: http://www.meps.ahrq.gov/ mepsweb/data§ats/download⊣ta/pufs/h36/h36u04doc.pdf. Accessed January 4, 2006.
7. Agency for Healthcare Research and Quality. MEPS HC-079: 2003 full year consolidated file; 2005. Available at: http://www.meps.ahrq.gov/mepsweb/ data§ats/download⊣ta/pufs/h79/h79doc.pdf. Accessed December 5, 2005.
8. Agency for Healthcare Research and Quality Medical Expenditure Panel Survey; 2005. Available at: http://www.meps.ahrq.gov/mepsweb /data§ats/ download⊣ta_files.jsp. Accessed November 8, 2006.
9. Agency for Healthcare Research and Quality. MEPS HC-067A: 2002 prescribed medicines; 2004. Available at: http://www.meps.ahrq.gov/ mepsweb/data§ats/download⊣ta/pufs/h67a/h67adoc.pdf. Accessed January 4, 2006.
10. Agency for Healthcare Research and Quality. MEPS HC-077A: 2003 prescribed medicines; 2005. Available at: http://www.meps.ahrq.gov/ mepsweb/data§ats/download⊣ta/pufs/h77a/h77adoc.pdf. Accessed January 4, 2006.
11. Moeller JF, Stagnitti M, Horan E, et al. Outpatient prescription drugs: data collection and editing in the 1996 Medical Expenditure Panel Survey (HC-010A). Rockville, MD: Agency for Healthcare Research and Quality; 2001. MEPS methodology report no. 12. AHRQ pub. no. 01-0002.
12. U.S. Dept. of Labor and Bureau of Labor Statistics. Consumer Price Index for all Urban Consumers; U.S. city average; all items. April 19, 2006 [updated January 18, 2007]. Available at: ftp://ftp.bls.gov/pub/ special.requests/cpi/cpiai.txt. Accessed August 30, 2005.
13. Curtis LH, Law AW, Anstrom KJ, Schulman KA. The insurance effect on prescription drug expenditures among the elderly: findings from the 1997 Medical Expenditure Panel Survey. Med Care. 2004;42:439-46.
14. Manski RJ, Macek MD, Moeller JF. Private dental coverage: who has it and how does it influence dental visits and expenditures? J Am Dent Assoc. 2002; 133:1551-59.
15. Poisal JA, Chulis GS. Medicare beneficiaries and drug coverage. Health Aff (Millwood). 2000;19:248-56.
16. Elixhauser A, Steiner C, Whittington C, McCarthy E. Clinical Classifications for Health Policy Research: Hospital Inpatient Statistics, 1995. Healthcare Cost and Utilization Project, HCUP-3 research note. Rockville, MD: Agency for Health Care Policy and Research; 2000. AHCPR pub. no. 98-0049.
17. Cerner Multum Lexicon Web site. Available at: http://www.multum.com/ Lexicon.htm. Accessed March 20, 2006.
18. Cubanski J, Voris M, Kitchman M, et al. Medicare Chartbook. 3rd ed. Menlo Park, CA: The Henry J. Kaiser Family Foundation; 2005.
19. The Kaiser Family Foundation. Medicare and prescription drugs, fact sheet. April 15, 2003. Available at: http://www.kff.org/medicare/ 1583-06-index.cfm. Accessed November 2, 2005.
20. Caplan C, Brangan N. Out-of-pocket spending on health care by Medicare beneficiaries age 65 and older in 2003. Washington, D.C.: AARP Public Policy Institute; 2004. Report no. DD101. Accessed February 11, 2006.
21. Beers MH. Explicit criteria for determimng potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157:1531-36.
22. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a U.S. consensus panel of experts. Arch Intern Med. 2003;163:2716-24.
23. Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging. 2005;22:69-82.
24. Simon SR, Chan KA, Soumerai SB, et al. Potentially inappropriate medication use by elderly persons in U.S. health maintenance organizations, 2000-2001. J Am Geriatr Soc. 2005;53:227-32.
25. Fillenbaum GG, Hanlon JT, Landerman LR, et al. Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. Am J Geriatr Pharmacother. 2004;2:92-101.
26. Stuart B, Kamal-Bahl S, Briesacher B, et al. Trends in the prescription of inappropriate drugs for the elderly between 1995 and 1999. Am J Geriatr Pharmacother. 2003;1:61-74.
27. Hanlon JT, Fillenbaum GG, Kuchibhatla M, et al. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care. 2002;40:166-76.
28. Hanlon JT, Lindblad CI, Hajjar ER, et al. Update on drug-related problems in the elderly. Am J Geriatr Pharmacother. 2003;1:38-43.
29. Blalock SJ, Byrd JE, Hansen RA, et al. Factors associated with potentially inappropriate drug utilization in a sample of rural community-dwelling older adults. Am J Geriatr Pharmacother. 2005;3:168-79.
30. Lindley CM, Tully MP, Paramsothy V, et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing. 1992; 21:294-300.
31. Stuck AE, Beers MH, Steiner A, et al. Inappropriate medication use in community-residing older persons. Arch Intern Med. 1994;154:2195-200.
32. Spore DL, Mor V,, Larrat P. et al. Inappropriate drug prescriptions for elderly residents of board and care facilities. Am J Public Health. 1997;87:404-09.
33. Hajjar ER, Hanlon JT, Sloane RJ, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc. 2005;53:1518-23.
34. Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract. 2005;17:123-32.
35. Atkin PA, Veitch PC, Veitch EM, et al. The epidemiology of serious adverse drug reactions among the elderly. Drugs Aging. 1999;14:141-52.
36. Sorensen L, Stokes JA, Purdie DM, et al. Medication management at home: medication-related risk factors associated with poor health outcomes. Age Ageing. 2005;34:626-32.
37. Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs. 2005;31:4-11.
38. Karas S Jr. The potential for drug interactions. Ann Emerg Med. 1981;10: 627-30.
39. Malone DC, Hutchins DS, Haupert H, et al. Assessment of potential drug-drug interactions with a prescription claims database. Am J Health Syst Pharm. 2005;62:1983-91.
40. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556-64.
41. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc. 2004;52:1349-54.
42. Field TS, Gilman BH, Subramanian S, et al. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care. 2005;43:1171-76.
43. Hepler CD, Strand LM, Tromp D, et al. Critically examining pharmaceutical care. J Am Pharm Assoc. 2002;42(5 suppl 1):S18-S19.
44. Zillich AJ, Sutherland JM, Kumbera PA, et al. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J Gen Intern Med. 2005;20:1091-96.
45. Carter BL, Zillich AJ. Pharmaceutical care services for patients with hypertension. Ann Pharmacother. 2003;37:1335-37.
46. Whellan DJ. Heart failure disease management: implementation and outcomes. Cardiol Rev. 2005;13:231-39.
47. Bouvy ML, Heerdink ER, Urquhart J, et al. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail. 2003;9:404-11.
48. Gattis WA, Hasselblad V, Whellan DJ, et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999;159:1939-45.
49. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev. 2000;CD000336.
50. Hanlon JT, Lindblad CI, Gray SL. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults? Am J Geriatr Pharmacother. 2004;2:3-13.
51. Carter BL, Malone DC, Billups SJ, et al. Interpreting the findings of the IMPROVE study. Am J Health Syst Pharm. 2001;58:1330-37.
52. Ellis SL, Carter BL, Malone DC, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000;20:1508-16.
53. Malone DC, Carter BL, Billups SJ, et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000;20:1149-58.
54. Christensen DB, Ferguson MS, Garrett DG, et al. Studying pharmaceutical care: difficult but necessary. J Am Pharm. Assoc. 2003;43(5 suppl 1):S36-S37.
55. Congressional Budget Office. High-cost Medicare beneficiaries. 2005. Available at: http://www.cbo.gov/ftpdocs/63xx/doc6332/ 05-03-MediSpending.pdf. Accessed November 15, 2005.